South East (Zuid Oost) Netherlands Heart Registry
Recruiting now
Conditions studied: Coronary Artery Disease, Acute Coronary Syndrome, Chronic Coronary Syndrome
In brief
Rationale: Patients undergoing percutaneous coronary intervention (PCI) for chronic coronary syndrome (CCS) or acute coronary syndrome (ACS) have a residual risk of ischemic events after PCI due to the progression of atherosclerosis in and outside the stented segments. The residual risk is affected by thrombotic, lipid, inflammation and diabetic risk factors. Secondary prevention after PCI is therefore of major importance to reduce complications and improve the patients' prognosis. Objective: To provide an extensive overview on the quality of secondary prevention and personalized medicine, a consortium in the South East Netherlands has created a PCI registry, the "Zuid Oost Nederland Hart Registratie" (ZON-HR).
Key facts
- Study ID
- NCT06512493
- Run by
- Radboud University Medical Center
- People needed
- 99999
- Starts
- 2020-11-01
- Expected to finish
- 2050-01-01
- Last updated by the study team
- 2024-07-25
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- ZuyderlandMC — Heerlen, Limburg, Netherlands (enrolling)
- MaastrichtUMC+ — Maastricht, Limburg, Netherlands (enrolling)
- VieCuri — Venlo, Limburg, Netherlands (enrolling)
- Radboud University Medical Centre — Nijmegen, Netherlands (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.